Avid Bioservices Inc (CDMO)

[revenue_monster]

again they only enrolled 3 patients so who cares what biomarkers were taken as the population is tiny.

Study Type : Interventional (Clinical Trial)
Actual Enrollment : 3 participants
Allocation: Randomized
Intervention Model: Parallel Assignment
Masking: None (Open Label)
Primary Purpose: Treatment
Official Title: A Two-Arm, Single Center Pase 1b Trial of Bavituximab Plus Ipilimumab in Advanced Melanoma Patients